We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Open or close the search fields display
42 Studies found for: ALEMTUZUMAB AND Monoclonal AND B-Cell AND Campath-1H AND Phase II

Terms and Synonyms Searched:

Terms Search Results* Entire Database**
Synonyms
ALEMTUZUMAB 42 studies 412 studies
campath 23 studies 258 studies
anti-CD52 monoclonal antibody 9 studies 23 studies
MoAb CD52 6 studies 9 studies
Monoclonal Antibody CD52 6 studies 9 studies
Anti-CD52 Antibody 1 studies 6 studies
MabCampath 1 studies 32 studies
Lemtrada -- 33 studies
Monoclonal 42 studies 7,549 studies
B-Cell 42 studies 6,148 studies
B lymphocyte 1 studies 393 studies
Lymphocytes B -- 15 studies
Campath-1H 42 studies 412 studies
ALEMTUZUMAB 41 studies 383 studies
campath 23 studies 258 studies
anti-CD52 monoclonal antibody 9 studies 23 studies
MoAb CD52 6 studies 9 studies
Monoclonal Antibody CD52 6 studies 9 studies
Anti-CD52 Antibody 1 studies 6 studies
MabCampath 1 studies 32 studies
Lemtrada -- 33 studies
Phase II 42 studies 80,525 studies
phase 2 40 studies 76,644 studies
2 phases -- 367 studies
phase two -- 139 studies
second phase -- 876 studies
Phase 42 studies 214,076 studies
Stage 23 studies 34,371 studies
Phased -- 204 studies

   
-- No studies found
* Number of studies in the search results containing the term or synonym
** Number of studies in the entire database containing the term or synonym